Form D · Other Technology
K Health, Inc.
New York, NY · CIK 0001689694
Offering snapshot reported Aug 19, 2026 · SEC filing
- Reported sold
- $58.9M Offering amount: $68.9M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 5, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2026 | Initial | $58,949,942 | No comparison | 19 | SEC filing |
| Jul 24, 2024 | Initial | $88,356,397 | No comparison | 26 | SEC filing |
| Jan 19, 2021 | Initial | $132,026,528 | No comparison | 16 | SEC filing |
| Nov 19, 2020 | Initial | $36,656,162 | No comparison | 9 | SEC filing |
| Mar 5, 2020 | Initial | $47,920,741 | No comparison | 21 | SEC filing |
| Jul 23, 2019 | Initial | $11,999,999 | No comparison | 1 | SEC filing |
| Dec 19, 2018 | Initial | $24,999,970 | No comparison | 15 | SEC filing |
| Jan 30, 2018 | Initial | $5,121,188 | No comparison | 10 | SEC filing |
| Jun 13, 2017 | Initial | $3,200,000 | No comparison | 7 | SEC filing |
| Nov 21, 2016 | Initial | $3,145,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594698
Source: Form D, filed Aug 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| C. Okey Agba | Director |
| Ashok Balakrishnan | Executive |
| Allon Bloch | Director, Executive |
| Saad Ehtisham | Director |
| Niyum Gandhi | Director |
| Antonio Gracias | Director |
| Vivek Pattipati | Director |
| Vivian Riefberg | Director |
| Yaron Savoray | Executive |
| Ran Shaul | Executive |
| Zac Siegel | Executive |
| Adam Singolda | Director |
| Mark Tluszcz | Director |
| Hans Tung | Director |
| Chen Yehudai | Executive |
| Nir Zohar | Director |
| Alejandro Zubillaga | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
387 Park Avenue South, 9th Floor
New York, NY, 10016
New York, NY, 10016